Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Sales | 225,887 | 242,829 | 250,890 | 273,722 | 195,365 |
| Cost of Goods | 138,475 | 146,752 | 149,286 | 169,111 | 119,489 |
| Gross Profit | 87,412 | 96,077 | 101,604 | 104,611 | 75,876 |
| Operating Expenses | 44,814 | 49,662 | 52,832 | 59,326 | 45,473 |
| Operating Income | 43,073 | 47,167 | 49,058 | 45,396 | 30,892 |
| Interest Expense | 6,595 | 4,777 | 5,706 | 7,246 | 5,410 |
| Other Income | 1,986 | 387 | 302 | 843 | 1,796 |
| Pre-tax Income | 38,464 | 42,777 | 43,654 | 38,993 | 27,278 |
| Income Tax | -19,171 | 12,349 | 12,223 | 10,860 | 8,174 |
| Net Income Continuous | 57,243 | 29,889 | 31,009 | 27,648 | 19,016 |
| Net Income Discontinuous | -6,825 | 2,184 | 851 | N/A | N/A |
| Net Income | $50,418 | $32,073 | $31,860 | $27,648 | $20,077 |
| EPS Basic Total Ops | 0.71 | 0.45 | 0.46 | 0.42 | 0.30 |
| EPS Basic Continuous Ops | 0.81 | 0.42 | 0.44 | 0.42 | 0.28 |
| EPS Basic Discontinuous Ops | -0.09 | 0.03 | 0.01 | N/A | N/A |
| EPS Diluted Total Ops | 0.68 | 0.44 | 0.44 | 0.40 | 0.29 |
| EPS Diluted Continuous Ops | 0.80 | 0.41 | 0.43 | 0.38 | 0.32 |
| EPS Diluted Discontinuous Ops | -0.09 | 0.03 | 0.01 | N/A | N/A |
| EBITDA(a) | $66,447 | $68,838 | $68,059 | $71,467 | $50,020 |